Article
Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication
21 Oct 2015
Abstract excerpt
Renal cell tumors (RCTs) are the most lethal of the common urological cancers. The widespread use of imaging entailed an increased detection of small renal masses, emphasizing the need for accurate distinction between benign and malignant RCTs, which is critical for adequate therapeutic management. Histone methylation has been implicated in renal tumorigenesis, but its potential clinical value as RCT biomarker...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
